Advertisement
Canada markets close in 5 hours 24 minutes
  • S&P/TSX

    21,889.86
    +95.96 (+0.44%)
     
  • S&P 500

    5,485.57
    +7.67 (+0.14%)
     
  • DOW

    39,223.47
    +95.67 (+0.24%)
     
  • CAD/USD

    0.7307
    +0.0007 (+0.10%)
     
  • CRUDE OIL

    81.65
    +0.75 (+0.93%)
     
  • Bitcoin CAD

    84,928.80
    +394.97 (+0.47%)
     
  • CMC Crypto 200

    1,294.80
    +28.66 (+2.26%)
     
  • GOLD FUTURES

    2,335.10
    +21.90 (+0.95%)
     
  • RUSSELL 2000

    2,025.73
    +7.62 (+0.38%)
     
  • 10-Yr Bond

    4.2850
    -0.0310 (-0.72%)
     
  • NASDAQ

    17,848.03
    +42.87 (+0.24%)
     
  • VOLATILITY

    12.40
    -0.15 (-1.19%)
     
  • FTSE

    8,214.77
    -10.56 (-0.13%)
     
  • NIKKEI 225

    39,341.54
    -325.53 (-0.82%)
     
  • CAD/EUR

    0.6815
    -0.0016 (-0.23%)
     

Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.

Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.

There were zero HIV cases among the 2,124 test subjects who received the antiviral injection called lenacapavir.